We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

25 Jun 2026 - 27 Jun 2026
02 Jul 2026 - 04 Jul 2026
08 Jul 2026 - 10 Jul 2026

Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities

By HospiMedica International staff writers
Posted on 18 Jun 2026

Danaher Corporation (Washington, DC, USA) has completed its acquisition of Masimo Corporation (Irvine, CA, USA), a specialty diagnostics provider known for pulse oximetry and advanced patient monitoring technologies used primarily in acute care settings. More...

The acquisition expands Danaher’s diagnostics portfolio by adding Masimo’s established brand, sensor technologies, and artificial intelligence-enabled monitoring solutions. The company stated the combination will enhance its ability to support healthcare providers with technologies designed to improve patient assessment and monitoring in hospitals and other acute care environments.

As part of the transaction, Masimo has become a wholly owned subsidiary of Danaher. The company will continue to operate under the Masimo brand as a stand-alone operating company within Danaher’s Diagnostics segment. Following completion of the acquisition, Masimo common stock has ceased trading on the Nasdaq Stock Market.

“Masimo is a strong strategic fit for Danaher. Together, we expect to strengthen our ability to deliver differentiated products in acute care settings and accelerate Masimo’s growth and global reach,” said Julie Sawyer Montgomery, Executive Vice President of Diagnostics at Danaher. “We are excited to welcome the Masimo team to Danaher.”


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Patient Monitoring System
AlarmSense
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A simple sensor placed on the infant’s forehead provides crucial information about cerebral blood flow and the amount of oxygen reaching the brain, as well as the amount that is extracted and consumed (Photo courtesy of Université de Montréal)

Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants

Premature birth, defined as delivery before 37 weeks of gestation, increases the risk of language, motor, and cognitive delays, yet many late preterm infants receive limited follow-up. Clinicians currently... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.